Annual Gross Profit:
$263.71M+$190.81M(+261.73%)Summary
- As of today, ESPR annual gross profit is $263.71 million, with the most recent change of +$190.81 million (+261.73%) on December 31, 2024.
- During the last 3 years, ESPR annual gross profit has risen by +$200.09 million (+314.53%).
- ESPR annual gross profit is now at all-time high.
Performance
ESPR Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Gross Profit:
$46.02M-$7.82M(-14.53%)Summary
- As of today, ESPR quarterly gross profit is $46.02 million, with the most recent change of -$7.82 million (-14.53%) on September 30, 2025.
- Over the past year, ESPR quarterly gross profit has increased by +$11.70 million (+34.09%).
- ESPR quarterly gross profit is now -78.26% below its all-time high of $211.72 million, reached on June 30, 2020.
Performance
ESPR Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM Gross Profit:
$176.80M+$11.70M(+7.09%)Summary
- As of today, ESPR TTM gross profit is $176.80 million, with the most recent change of +$11.70 million (+7.09%) on September 30, 2025.
- Over the past year, ESPR TTM gross profit has dropped by -$64.19 million (-26.63%).
- ESPR TTM gross profit is now -32.95% below its all-time high of $263.68 million, reached on December 31, 2024.
Performance
ESPR TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
ESPR Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +261.7% | +34.1% | -26.6% |
| 3Y3 Years | +314.5% | +272.1% | +305.4% |
| 5Y5 Years | +100.0% | +1255.5% | -18.5% |
ESPR Gross Profit Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +449.3% | -64.0% | +272.1% | -33.0% | +305.4% |
| 5Y | 5-Year | at high | >+9999.0% | -64.0% | +1255.5% | -33.0% | +342.6% |
| All-Time | All-Time | at high | >+9999.0% | -78.3% | >+9999.0% | -33.0% | >+9999.0% |
ESPR Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $46.02M(-14.5%) | $176.80M(+7.1%) |
| Jun 2025 | - | $53.84M(+60.9%) | $165.10M(-2.6%) |
| Mar 2025 | - | $33.46M(-23.1%) | $169.47M(-35.7%) |
| Dec 2024 | $263.71M(+261.7%) | $43.48M(+26.7%) | $263.68M(+9.4%) |
| Sep 2024 | - | $34.32M(-41.0%) | $240.99M(+6.1%) |
| Jun 2024 | - | $58.22M(-54.4%) | $227.23M(+20.9%) |
| Mar 2024 | - | $127.66M(+514.0%) | $187.97M(+157.8%) |
| Dec 2023 | $72.90M(+51.9%) | $20.79M(+1.1%) | $72.90M(+9.3%) |
| Sep 2023 | - | $20.57M(+8.5%) | $66.68M(+14.0%) |
| Jun 2023 | - | $18.95M(+50.4%) | $58.48M(+19.2%) |
| Mar 2023 | - | $12.60M(-13.5%) | $49.05M(+2.2%) |
| Dec 2022 | $48.01M(-24.5%) | $14.57M(+17.8%) | $48.01M(+10.1%) |
| Sep 2022 | - | $12.37M(+30.0%) | $43.62M(+9.2%) |
| Jun 2022 | - | $9.52M(-17.7%) | $39.94M(-42.2%) |
| Mar 2022 | - | $11.56M(+13.6%) | $69.14M(+8.7%) |
| Dec 2021 | $63.62M(-71.7%) | $10.17M(+17.0%) | $63.62M(+3.9%) |
| Sep 2021 | - | $8.70M(-77.5%) | $61.23M(+9.5%) |
| Jun 2021 | - | $38.71M(+540.7%) | $55.93M(-75.6%) |
| Mar 2021 | - | $6.04M(-22.5%) | $228.95M(+1.9%) |
| Dec 2020 | $224.61M(>+9900.0%) | $7.79M(+129.5%) | $224.61M(+3.6%) |
| Sep 2020 | - | $3.40M(-98.4%) | $216.82M(+1.6%) |
| Jun 2020 | - | $211.72M(>+9900.0%) | $213.42M(>+9900.0%) |
| Mar 2020 | - | $1.70M(>+9900.0%) | $1.70M(>+9900.0%) |
| Dec 2019 | $0.00(+100.0%) | $0.00(0.0%) | $0.00(+100.0%) |
| Sep 2019 | - | $0.00(0.0%) | -$74.00K(+47.5%) |
| Jun 2019 | - | $0.00(0.0%) | -$141.00K(+30.9%) |
| Mar 2019 | - | $0.00(+100.0%) | -$204.00K(+23.0%) |
| Dec 2018 | -$265.00K | -$74.00K(-10.4%) | -$265.00K(-4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$67.00K(-6.3%) | -$253.00K(-2.0%) |
| Jun 2018 | - | -$63.00K(-3.3%) | -$248.00K(+0.8%) |
| Mar 2018 | - | -$61.00K(+1.6%) | -$250.00K(+3.1%) |
| Dec 2017 | -$258.00K(-2.4%) | -$62.00K(0.0%) | -$258.00K(0.0%) |
| Sep 2017 | - | -$62.00K(+4.6%) | -$258.00K(+0.4%) |
| Jun 2017 | - | -$65.00K(+5.8%) | -$259.00K(-0.8%) |
| Mar 2017 | - | -$69.00K(-11.3%) | -$257.00K(-2.0%) |
| Dec 2016 | -$252.00K(-6.8%) | -$62.00K(+1.6%) | -$252.00K(+1.9%) |
| Sep 2016 | - | -$63.00K(0.0%) | -$257.00K(-3.6%) |
| Jun 2016 | - | -$63.00K(+1.6%) | -$248.00K(-2.9%) |
| Mar 2016 | - | -$64.00K(+4.5%) | -$241.00K(-2.1%) |
| Dec 2015 | -$236.00K(-47.5%) | -$67.00K(-24.1%) | -$236.00K(-4.9%) |
| Sep 2015 | - | -$54.00K(+3.6%) | -$225.00K(-1.4%) |
| Jun 2015 | - | -$56.00K(+5.1%) | -$222.00K(-7.2%) |
| Mar 2015 | - | -$59.00K(-5.4%) | -$207.00K(-29.4%) |
| Dec 2014 | -$160.00K(-126.6%) | -$56.00K(-9.8%) | -$160.00K(-39.3%) |
| Sep 2014 | - | -$51.00K(-24.4%) | -$114.90K(-54.4%) |
| Jun 2014 | - | -$41.00K(-241.7%) | -$74.40K(-122.8%) |
| Mar 2014 | - | -$12.00K(-10.1%) | -$33.40K(-56.1%) |
| Dec 2013 | -$70.60K(+49.4%) | -$10.90K(-3.8%) | -$21.40K(-103.8%) |
| Sep 2013 | - | -$10.50K(>-9900.0%) | -$10.50K(>-9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00(+100.0%) | $0.00(+100.0%) |
| Dec 2012 | -$139.40K(+21.9%) | - | - |
| Mar 2012 | - | -$36.90K | -$36.90K |
| Dec 2011 | -$178.50K(+77.2%) | - | - |
| Dec 2000 | -$784.00K(-15.0%) | - | - |
| Dec 1999 | -$682.00K | - | - |
FAQ
- What is Esperion Therapeutics, Inc. annual gross profit?
- What is the all-time high annual gross profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. annual gross profit year-on-year change?
- What is Esperion Therapeutics, Inc. quarterly gross profit?
- What is the all-time high quarterly gross profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. quarterly gross profit year-on-year change?
- What is Esperion Therapeutics, Inc. TTM gross profit?
- What is the all-time high TTM gross profit for Esperion Therapeutics, Inc.?
- What is Esperion Therapeutics, Inc. TTM gross profit year-on-year change?
What is Esperion Therapeutics, Inc. annual gross profit?
The current annual gross profit of ESPR is $263.71M
What is the all-time high annual gross profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high annual gross profit is $263.71M
What is Esperion Therapeutics, Inc. annual gross profit year-on-year change?
Over the past year, ESPR annual gross profit has changed by +$190.81M (+261.73%)
What is Esperion Therapeutics, Inc. quarterly gross profit?
The current quarterly gross profit of ESPR is $46.02M
What is the all-time high quarterly gross profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high quarterly gross profit is $211.72M
What is Esperion Therapeutics, Inc. quarterly gross profit year-on-year change?
Over the past year, ESPR quarterly gross profit has changed by +$11.70M (+34.09%)
What is Esperion Therapeutics, Inc. TTM gross profit?
The current TTM gross profit of ESPR is $176.80M
What is the all-time high TTM gross profit for Esperion Therapeutics, Inc.?
Esperion Therapeutics, Inc. all-time high TTM gross profit is $263.68M
What is Esperion Therapeutics, Inc. TTM gross profit year-on-year change?
Over the past year, ESPR TTM gross profit has changed by -$64.19M (-26.63%)